French metabolic diseases biotech company Poxel has secured approval for a first-in-class type 2 diabetes medicine, Twymeeg (imeglimin hydrochloride). 24 June 2021
Shares in New Jersey, USA-based company Provention Bio rose by over a quarter on Tuesday, after the firm announced positive regulatory news related to its type 26 May 2021
Eli Lilly’s tirzepatide has achieved all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiova 21 May 2021
Eli Lilly (NYSE: LLY) underwhelmed with its first-quarter financial results, sending its share price tumbling by 2% by lunchtime on Tuesday. 27 April 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.